[1] |
Pavlidis N, Fizazi K. Carcinoma of unknown primary[J]. Crit Rev Oncol Hematol, 2009, 69(3): 271-8. doi: 10.1016/j.critrevonc.2008.09.005
|
[2] |
Kwee TC, Basu S, Cheng G, et al. FDG PET/CT in carcinoma of unknown primary[J]. Eur J Nucl Med Mol Imaging, 2010, 37(7): 635-44.
|
[3] |
Pavlidis N, Briasoulis E, Hainsworth J, et al. Diagnostic and therapeutic management of cancer of unknown primary[J]. Eur J Cancer, 2003, 39(18): 1990-2005.
|
[4] |
Chorost MI, Lee MC, Yeoh CB, et al. Unknown primary[J]. J Surg Oncol, 2004, 15, 87(2): 191-203.
|
[5] |
Haas I, Hoffmann TK, Engers R, et al. Diagnostic strategies in cervical carcinoma of an unknown primary[J]. Eur Arch Otorhinolaryngol, 2002, 259(2): 325-33.
|
[6] |
Antoch G, Vogt FM, Freudenberg LS, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology[J]. JAMA, 2003, 290(20): 3199-206.
|
[7] |
Nam EJ, Yun MJ, Oh YT, et al. Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI[J]. Gynecol Oncol, 2010, 116(4): 389-94.
|
[8] |
Shim SS, Lee KS, Kim BT, et al. Nonsmall cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging[J]. Radiology, 2005, 236(12): 1011-9.
|
[9] |
Sève P, Billotey C, Broussolle C, et al. The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site[J]. Cancer, 2007, 109(3): 292-9.
|
[10] |
Rusthoven KE, Koshy M, Paulino AC. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor[J]. Cancer, 2004, 101(31): 2641-9.
|
[11] |
Delgado RC, Fernández-Pérez C, González-Maté A, et al. Meta analysis of the performance of 18F-FDG PET in primary tumor detection in unknown primary tumors[J]. J Nucl Med, 2003, 44(11): 1301-4.
|
[12] |
Yanpar Z, Kibar M, Yapar AF, et al. The value of 18F-fluorodeoxyglucose positron emission tomography/compuied tomography in carcinoma of an unknown primary: diagnosis and follow-up[J]. Nucl Med Commun, 2010, 31(1): 59-66. doi: 10.1097/MNM.0b013e328332b340
|
[13] |
Chorost MI, Lee MC, Yeoh CB, et al. Unknown primary[J]. J Surg Oncol, 2004, 87(4): 191-203. doi: 10.1002/jso.20099
|
[14] |
Gutzeit A, Antoch G, Kühl H, et al. Unknown primary tumors:detection with dual-modality PET/CT--initial experience[J]. Radiology, 2005, 234(3): 227-34.
|
[15] |
Lee JR, Kim JS, Roh JL, et al. Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study[J]. Radiology, 2015, 274(8): 764-71.
|
[16] |
Lonneux M, Reffad A. Metastases from unknown primary tumor. PET-FDG as initial diagnostic procedure[J]. Clin Positron Imaging, 2000, 3(5): 137-41.
|
[17] |
Rusthoven KE, Koshy M, Paulino AC. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor[J]. Cancer, 2004, 101(12): 2641-9.
|
[18] |
Bohuslavizki KH, Klutmann S, Kröger S, et al. FDG PET detection of unknown primary tumors[J]. J Nucl Med, 2000, 41(6): 816-22.
|
[19] |
Han A, Xue J, Hu M, et al. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary[J]. Cancer Epidemiol, 2012, 36(2): 470-5.
|
[20] |
Riaz S, Nawaz MK, Faruqui ZS, et al. Diagnostic accuracy of 18F-Fluorodeoxyglucose positron emission tomography-computed tomography in the evaluation of carcinoma of unknown primary[J]. Mol Imaging Radionucl Ther, 2016, 25(6): 11-8.
|
[21] |
Pelosi E, Pennone M, Deandreis D, et al. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site[J]. Q J Nucl Med Mol Imaging, 2006, 50(4): 15-22.
|
[22] |
Wang G, Wu Y, Zhang W, et al. Clinical value of whole-body F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with carcinoma of unknown primary[J]. J Med Imaging Radiat Oncol, 2013, 57(2): 65-71.
|
[23] |
Kwee TC, Kwee RM. Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis[J]. Eur Radiol, 2009, 19(5): 731-44.
|
[24] |
郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19-28. doi: 10.3760/cma.j.issn.0253-3766.2019.01.005
|
[25] |
Fletcher JW, Djulbegovic B, Soares HP, et al. Recommendations on the use of 18F-FDG PET in oncology[J]. J Nucl Med, 2008, 49(19): 480-508.
|
[26] |
Elboga U, Kervancioglu S, Sahin E, et al. Utility of 18F-fluorodeoxyglucose positron emission tomography/computed in carcinoma of unknown primary[J]. Int J Clin Exp Pathol, 2014, 7(12): 8941-6.
|